This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Yet, the healthcare experience often begins with a decidedly analog ritual: The dreaded patient intake form. While medicalscience advances, too many clinics still rely on cumbersome paperwork. Its simple: Digital patient intake forms. What is Digital Patient Intake? Whats the solution to such an age-old problem?
Traditionally, Medical Affairs has focused on cross-functional collaboration with commercial and R&D teams, medical communication, evidence generation, and dissemination. At the same time, MSLs are being asked to help inform brand strategy with their learnings from talking to leading healthcare professionals.
In the healthcare Operations field, achieving the best possible patient outcomes is paramount. This means ensuring patients not only understand their diagnosis but are also empowered to participate actively in their treatment plan. It utilizes computer-generated simulations to create realistic and interactive environments.
Personalized Medicine Thanks to AI, we will create simulations of the human body at the molecular, cellular and organ levels, allowing treatments to be personalized for each patient. This will lead to treatments that are more effective and safer, as the specificities of each patient will be taken into account.
In both cases, this leads to data-driven coaching for where the individual needs improvement most. Salesforce Life Sciences Cloud as the Training Hub In 2025, Salesforce Life Sciences Cloud is no longer just a CRMits the nerve center for sales training and compliance.
In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs). Rarely are organisations able to view HCP relationships holistically – across clinical, medical, and sales – or reap the benefits of creating a unified understanding of the customer.
Medical communications must be able to offer useful information to HCPs when questions arise, whether that’s in the clinic with a patient or in a surgical theatre.
“NEJM is pleased to participate in an innovative new service from CCC that aligns with our goal to meet the information needs of researchers for the highest quality studies in medicalscience,” said Rob McKinney, Director, NEJM Group Licensing. NEJM is recognized as the world’s leadingmedical journal and website.
In this era of grab-and-go learning, continuing medical education (CME) is being transformed by digital and AI technology, which tailors learning to meet individual HCP needs. This approach enhances patient outcomes and care by delivering education at the most receptive moments for healthcare professionals.
As medical treatments become more complex, the role of the MedicalScience Liaison (MSL) has never been more important. Louise Picken , EVP Head of Medical Services, Complete HealthVizion. She brings over 20 years of experience in medical communications and medical training.
The primary purpose of MedicalScience Liaison MSL is to establish and maintain peer-peer relationships with leading physicians, referred to as Key Opinion Leaders KOL’s, at major academic institutions and clinics. Asking strategic questions leads to a better understanding of medical practices and habits.
This leads to substantial damage to healthy tissues and too often results in poor outcomes. The rest of the patients had partial responses. with ten patients to try to duplicate the results. which are currently recruiting patients. In Israel, the company already has a ministry of health approval to treat patients.
All of these systems operate under the “master-slave” concept, which involves a surgeon sitting behind a console, away from the patient, who manipulates the mechanical arms of the robot via some kind of joystick-like device. More info can be found at the Biomed Israel website.
Following their introduction, these therapies have moved to early lines of treatment, but unfortunately, a significant number of patients are not cured with these approaches. As a result, when the patient’s lymphoma relapses after treatment with chemotherapy, BV and CPIs, there are no effective treatment alternatives for these patients.
Although effective, the inconvenience of regular injections can lead to poor patient adherence, with studies showing that persistence and adherence are generally better for oral medications compared with injections. We can see a future where millions of patients no longer carry the burden of regular injections.”
This engagement is continuing to remain high, with evolving requirements and preferences of healthcare practitioners (HCPs) in the ways they engage with pharma reps and medicalscience liaisons (MSLs) through virtual communications. Five steps to closing the CX gap with HCPs and Patients. Get stakeholder buy in on the “why”.
Medicalscience Liaisons know that change is coming; How are they cashing in? Medicalscience liaisons (MSLs) within pharmaceutical companies deal in a special currency: scientific exchange and real-world insights gathering.
When the first biosimilars were approved by the FDA almost a decade ago, they were expected to provide a cost-effective alternative to expensive biologics, improve accessibility for patients and reduce healthcare spending by creating competition in the biologic market. Overall, the findings of the analysis were positive.
AI is also making waves in how to find and target patient communities as healthcare privacy legislation continues to expand in the United States. Dstillery, a custom audience solution, predicts impression opportunities through AI modeling that identifies patient patterns without using any cookie-based identification.
The time-consuming and resource-intensive path from the lab bench to the patient bedside starts with drug discovery, progresses to pre-clinical and clinical research, and then enters regulatory review. Any misstep in terms of pricing, reimbursement, or marketing could mean delays in providing therapies to the patients who need them most.
Neuromodulation isn’t just about stimulating nerves; it’s about awakening hope and transforming lives—one patient at a time. In this episode, Blake Williams takes us on a wild journey through his career as a Field Clinical Engineer (FCE), shedding light on the incredible impact of neuromodulation on the lives of patients.
Healthcare providers (HCPs), payers, and patients can now access medical information at their fingertips and they expect more from Pharma than in the past. This increased focus on patients and diverse stakeholders will undoubtedly be facilitated by the accelerated uptake of digital tools and virtual collaboration solutions.
We also step into her world outside of workher excitement about becoming a mother, her love of fantasy novels, and how her personal values shape the way she leads and connects with people. In this podcast, I interview top medical sales reps and leadingmedical sales executives across the entire world. There has to.
contact information, medical specialties, accepted insurances, business hours, location, patient testimonials, and more) directly on the SERP. MedicalSpecialty Any specific branch of medicalscience or practice, including clinical specialties about organ systems and their respective diseases and allied health specialties.
With this comes new hope for previously underserved patient populations. Acting as a go-between for pharma and physicians, medicalscience liaisons (MSLs) are responsible for communicating necessary information about new medicines to healthcare professionals and key opinion leaders (KOLs). A fresh approach. Expanding horizons.
This means that during the Q&A session, you may face a myriad of intricate medical, functional, or operational questions. A MedicalScience Liaison’s job is to build relationships, so distinguishing yourself in these ways is paramount. For a MedicalScience Liaison, having medical knowledge is a given necessity.
They have to meet with doctors, nurses, and healthcare administrators to whom they will have to present products, conduct demonstrations, and discuss patient needs and how offering meets them. National Sales Director: Lead strategy for the entire sales division, and manage teams across regions.
As treatments become more tailored to individual patients, sales reps must understand complex scientific concepts and communicate them effectively. You need to comprehend and convey how these products can truly make a difference in patients' lives. Another game-changer has been the shift towards personalized medicine.
Cancer remains a global threat with around 10 million people dying from the disease each year worldwide, making it the second leading cause of death. 3 With greater scientific understanding of cancer, the industry has made significant progress in developing innovative medicines to help patients. 1,2 In the EU, an estimated 2.7
Academy of MedicalSciences. “I I am honoured to be succeeding [ Dr Mikael Dolsten ] and to be taking on leadership of a combined R&D organisation that includes… a promising pipeline of innovative medicines and vaccines candidates poised to have a tremendous impact for patients globally,” shared Dr Boshoff.
1 Particularly, CAR-T cell therapy, which uses a patient’s T-cells to fight cancer by altering them so they can find and destroy cancer cells, has emerged as a valuable option for many patients. 2 With this new indication, more patients will be able to access this innovative treatment.
Career success in MedTech is not just about climbing the corporate ladder; it’s about relentlessly advocating for patients, embracing change, and, above all, never giving up. It’s one of those interviews that can stick with you and inspire you as you continue to go on and lead the wonderful career you are trying to lead.
Manufacturing woes have affected both cell and gene-modified cell therapies in oncology recently, disadvantaging patients with multiple myeloma (MM) and melanoma. DELTA-1 is a Phase II single-arm trial in metastatic melanoma, evaluating the efficacy of ITIL-168 in patients who have progressed on previous therapy.
This disruption has changed the way doctors and cancer patients expect to experience services and products, and there is no going back now. Takeda Connect provides oncologists with information about their Key Account Manager and MedicalScience Liaison, alongside direct access at the click of a button.
1 The cancer is a slow-growing but potentially life-threatening B-cell malignancy, in which increased activation of B-cell receptor signalling pathways leads to overgrowth of lymphocytes in bone marrow and other disease compartments. for all-comers; HR=0.52
This is due to aging populations around the world, which leads to an increased risk of such conditions, explains Craig Beavers, PhD, assistant professor at the University of Kentucky’s College of Pharmacy in Lexington. These] are life-saving medications. And patients can die when we do not have these readily available,” he says.
This interaction enables the immune effector cells to target and kill cancer cells more effectively, significantly benefiting patients. A prime example is our drug, Carvykti, which has demonstrated spectacular results, offering long-lasting remissions with a single dose in patients undergoing various prior lines of therapy.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content